Total Payments
$1,651
2024 Payments
$170.20
Companies
12
Transactions
89
Medicare Patients
1,413
Medicare Billing
$169,366
Payment Breakdown by Category
Food & Beverage$1,645 (99.6%)
Education$6.00 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,645 | 88 | 99.6% |
| Education | $6.00 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $730.03 | 35 | $0 (2024) |
| Lilly USA, LLC | $219.64 | 13 | $0 (2023) |
| Novo Nordisk Inc | $218.60 | 12 | $0 (2024) |
| PFIZER INC. | $161.38 | 11 | $0 (2021) |
| Corcept Therapeutics | $90.64 | 5 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $65.17 | 2 | $0 (2018) |
| Teva Pharmaceuticals USA, Inc. | $45.91 | 2 | $0 (2021) |
| Amgen Inc. | $39.51 | 3 | $0 (2021) |
| Supernus Pharmaceuticals, Inc. | $25.98 | 2 | $0 (2019) |
| ABBVIE INC. | $25.49 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $170.20 | 10 | Corcept Therapeutics ($90.64) |
| 2023 | $110.76 | 7 | Lilly USA, LLC ($47.70) |
| 2022 | $69.11 | 4 | AstraZeneca Pharmaceuticals LP ($57.45) |
| 2021 | $292.74 | 17 | AstraZeneca Pharmaceuticals LP ($149.55) |
| 2020 | $282.26 | 19 | AstraZeneca Pharmaceuticals LP ($138.75) |
| 2019 | $398.85 | 14 | AstraZeneca Pharmaceuticals LP ($248.36) |
| 2018 | $216.81 | 11 | Novo Nordisk Inc ($50.37) |
| 2017 | $109.86 | 7 | AstraZeneca Pharmaceuticals LP ($50.07) |
All Payment Transactions
89 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/11/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Endocrinology | ||||||
| 09/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Respiratory | ||||||
| 08/20/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Endocrinology | ||||||
| 08/14/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Diabetes | ||||||
| 04/09/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: Endocrinology | ||||||
| 02/27/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Respiratory | ||||||
| 02/22/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: Diabetes | ||||||
| 02/21/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Endocrinology | ||||||
| 01/09/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: Endocrinology | ||||||
| 11/09/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Diabetes | ||||||
| 11/08/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Obesity | ||||||
| 10/30/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Diabetes | ||||||
| 08/22/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.56 | General |
| 07/20/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Diabetes | ||||||
| 03/23/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Respiratory | ||||||
| 01/06/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Diabetes | ||||||
| 12/13/2022 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $22.07 | General |
| 10/24/2022 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $21.32 | General |
| 04/20/2022 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: Diabetes | ||||||
| 03/17/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Respiratory | ||||||
| 12/07/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Diabetes | ||||||
| 12/01/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/21/2021 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Neuroscience | ||||||
| 10/08/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 361 | 651 | $112,815 | $41,059 |
| 2022 | 7 | 300 | 538 | $89,465 | $35,381 |
| 2021 | 8 | 384 | 718 | $98,410 | $46,828 |
| 2020 | 10 | 368 | 770 | $109,982 | $46,098 |
Total Patients
1,413
Total Services
2,677
Medicare Billing
$169,366
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 92 | 243 | $57,105 | $20,678 | 36.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 76 | 76 | $19,000 | $9,685 | 51.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 75 | 136 | $23,800 | $7,747 | 32.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $4,355 | $1,067 | 24.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 52 | 74 | $2,220 | $696.88 | 31.4% |
| 11721 | Removal of fingernails or toenails, 6 or more nails | Office | 2023 | 12 | 18 | $1,620 | $595.68 | 36.8% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 13 | 13 | $1,495 | $504.53 | 33.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 17 | 61 | $3,050 | $47.24 | 1.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 11 | 17 | $170.00 | $37.40 | 22.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 72 | 187 | $40,865 | $15,316 | 37.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 72 | 140 | $22,880 | $8,183 | 35.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 59 | 59 | $14,270 | $7,709 | 54.0% |
| 11721 | Removal of fingernails or toenails, 6 or more nails | Office | 2022 | 28 | 54 | $4,860 | $1,920 | 39.5% |
| 11730 | Simple separation of fingernail or toenail from nail bed, first nail | Office | 2022 | 11 | 12 | $2,580 | $1,022 | 39.6% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 44 | 72 | $2,520 | $677.74 | 26.9% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 14 | 14 | $1,490 | $553.92 | 37.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 101 | 292 | $56,940 | $25,138 | 44.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 80 | 80 | $16,800 | $10,683 | 63.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 72 | 105 | $14,175 | $6,580 | 46.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 12 | 12 | $3,720 | $2,029 | 54.6% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 68 | 137 | $4,110 | $1,313 | 32.0% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 25 | 25 | $1,875 | $993.25 | 53.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 12 | 47 | $590.00 | $46.60 | 7.9% |
| 81003 | Automated urinalysis test | Office | 2021 | 14 | 20 | $200.00 | $45.00 | 22.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 118 | 410 | $77,040 | $30,261 | 39.3% |
About Dr. J Rauh, MD
Dr. J Rauh, MD is a Obstetrics & Gynecology healthcare provider based in Miles City, Montana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1649378530.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. J Rauh, MD has received a total of $1,651 in payments from pharmaceutical and medical device companies, with $170.20 received in 2024. These payments were reported across 89 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,645).
As a Medicare-enrolled provider, Rauh has provided services to 1,413 Medicare beneficiaries, totaling 2,677 services with total Medicare billing of $169,366. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Location Miles City, MT
- Active Since 09/21/2006
- Last Updated 01/05/2021
- Taxonomy Code 207V00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1649378530
Products in Payments
- FARXIGA (Drug) $434.82
- Ozempic (Drug) $135.62
- Korlym (Drug) $90.64
- EMGALITY (Drug) $73.43
- TRULICITY (Drug) $70.03
- EUCRISA (Drug) $68.33
- MOUNJARO (Drug) $47.70
- ELIQUIS (Drug) $39.61
- LYRICA (Drug) $37.70
- AJOVY (Drug) $34.18
- AIRSUPRA (Drug) $33.60
- Rybelsus (Drug) $32.46
- JARDIANCE (Drug) $28.48
- BREZTRI (Drug) $27.46
- TROKENDI XR (Drug) $25.98
- Victoza (Drug) $18.52
- Wegovy (Drug) $17.30
- Trintellix (Drug) $17.24
- CHANTIX (Drug) $15.74
- STIOLTO (Drug) $15.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.